This site is intended for health professionals only
Thursday 27 June 2019
Share |

Rights bought for Huntingdon's drug

Cambridge Laboratories in Ireland will benefit from the acquisition of Prestwick Pharmaceuticals and related license rights for $100 million by pharmaceutical company Biovail.

US-based Prestwick holds the Canadian and US licensing rights to xenazine tetrabenazine tablets – of which Cambridge is the worldwide license holder.

The US Food and Drug Administration recently approved xenazine for the treatment of chorea associated with Huntington's, a devastating neurodegenerative disease.

In line with an agreement between Prestwick and Ovation Pharmaceuticals, Biovail will supply xenazine to Ovation for a variable percentage of the product's annual net sales.

Up to $125 million, Biovail's supply price will be 72% of net sales, 65% beyond $125 million. At both tiers, Biovail will pay 50% of net sales to Cambridge. The launch is expected later this year.

Beyond xenazine, the acquisition also provides Biovail with other early-stage products, including treatment for Parkinson's disease and schizophrenia.

Biovail's chief executive officer, Bill Wells, said: "The transaction meets all of our acquisition criteria, and represents Biovail's first commercial exposure to speciality markets in central nervous system (CNS) disorders. The acquisition is another important step in the implementation of our new strategic focus."

Copyright PA Business 2008

Biovail

Ads by Google

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine